In February, the Trump administration launched TrumpRx, a government website that provides prescription drug discounts to consumers. This brief examines issues that may impact consumers, especially those with private insurance, who access drug discounts through TrumpRx.
Recent Posts
- WTW expands digital asset protection offering through Redefind acquisition
- Helene Madell to lead Aon’s Global Broking Centre as CEO
- Insurance tech specialist Sapiens gets investment from ADIA
- Howden Re flags ‘stark contrast’ between pricing trends and broader risk environment
- Canopius appoints Steve Parry as Group Chief Claims Officer



